Latest "Placebo Hepatitis Virus Infection" News Stories

19:41 EDT 4th October 2015 | BioPortfolio

Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.

More Information about Placebo Hepatitis Virus Infection on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.

Showing "Placebo Hepatitis Virus Infection" News Articles 1–25 of 6,700+

Extremely Relevant

Seals Harbor Hepatitis A-Like Virus

Scientists in the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A. The research appears in the July/August issue of mBio, the online open-access journal of the American Society for Microbi...

Lives Could Be Saved with New Hepatitis C Therapy

In a letter to the Medical Journal of Australia, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths. Hepatitis C virus (HCV) infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected.

Hepatitis A-like virus identified in seals

(American Society for Microbiology) Scientists in the Center for Infection and Immunity at the Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provide...

CDC Observes 20th Anniversary of Hepatitis Awareness Month

This month marks the 20th anniversary of Hepatitis Awareness Month and the 4th National Hepatitis Testing Day (May 19) in the United States. Although care and treatment can be life-saving, many of the 3 million persons estimated to be living with hepatitis C virus (HCV) infection are unaware of their infection and are not receiving preventive

Use of Antihistamine Compounds for the Treatment of Hepatitis C Virus

The vast majority of people infected with Hepatitis C Virus (HCV) will have chronic infection. Over decades, this can lead to liver disease and liver cancer. In fact, HCV infection is the leading cause of liver transplants in the U.S. Several new drugs have recently come into the market that will likely change the HCV treatment paradigm. However, the effectiveness of these new drugs c...

Alcohol use disorders - stronger predictor of mortality than chronic hepatitis C virus infection

(European Association for the Study of the Liver) Results presented today at The International Liver Congress™ 2015, show that alcohol use disorders (AUD) have a serious, negative prognostic outcome with higher mortality risks in the general popula...

Continued Progress Against Hepatitis C Infection

This Viewpoint describes clinical progress in eradicating hepatitis C virus infection, but emphasizes the importance of making treatment more cost-effective and accessible to all patients.

Expression of a Single Gene Lets Scientists Grow Hepatitis C Virus in the Lab

Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and developing new effective treatments. In a study published in Nature on August

The Lancet Infectious Diseases Journal Publishes Results of Phase 2 Study of Lonafarnib in Hepatitis Delta Virus (HDV) Infected Patients

PALO ALTO, Calif., July 20, 2015 /PRNewswire/ -- Eiger BioPharmaceuticals Incorporated announced today the publication of results of the first Phase 2a study of lonafarnib in patients with chronic hepatitis delta virus (HDV) infection.  The study was conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.  The double-blinded, randomized, placebo-contro...

Hepatitis: New mouse model provides novel insights into hepatitis D virus infection and clearance

AbbVie gets FDA approval for Hepatitis C combination therapy

(Reuters) - The U.S. Food and Drug Administration approved AbbVie Inc's treatment that targets hepatitis C virus with the rarest genotype, or genetic makeup. About 2.7 million Americans are infected with hep C virus, of which genotype 4 is among the ...

NIH Study Suggests Alternative Drug to Treat Hepatitis C Virus Infection

An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.

Scientists Identify Crucial Step in Helping to Prevent Hepatitis C Virus Replication

New research from the University of Southampton has identified how changes in the cell membrane play a pivotal role in how the hepatitis C virus replicates. By understanding this process, the researchers hope to investigate how to prevent the changes and potentially develop therapeutic drugs to combat the hepatitis C virus (HCV), which infects an

Differences in Liver Cancer Attributable to Hepatitis Virus Variations

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -- hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly

New virus identified in blood supply

Scientists have discovered a new virus that can be transmitted through the blood supply. Currently, it is unclear whether the virus is harmful or not, but it is related to hepatitis C virus (HCV) and human pegivirus (HPgV), the latter of which was fo...

Hepatitis C infection may fuel heart risk

(Johns Hopkins Medicine) People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble.

Hepatitis C: Updated Guidelines and New Drugs

The latest drugs to be approved for the treatment of hepatitis C virus infection are setting new standards of practice. Medscape Pharmacists

Crucial step in helping to prevent Hepatitis C virus replicating identified

New research has identified how changes in the cell membrane play a pivotal role in how the Hepatitis C virus replicates. By understanding this process, the researchers hope to investigate how to prevent the changes and potentially develop therapeuti...

The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA

In this Review, Lemon and colleagues describe the interactions of the RNA genome of hepatitis C virus with various host proteins and microRNAs. They discuss how these interactions affect viral RNA synthesis and decay, and how they influence the long-...

Benitec doses fifth patient in Phase I/IIa trial of TT-034 to treat hepatitis C virus

Benitec Biopharma is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has been dosed at the Duke Clinical Research Unit.

Cancer drug shows promise as cure for hepatitis B

Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.

Risk of hepatitis D higher among HIV infected and injection drug users

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country. The study, published in ...

Migration contributes to flat HBV infection prevalence rate in US

(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.

Screening for Hepatitis C

This JAMA Clinical Guidelines Synopsis summarizes the most recent US Preventive Services Task Force guidelines on screening for hepatitis C virus infection in adults.

More Hepatitis C Cases Being Seen in Urban ERs

FRIDAY, Aug. 7, 2015 -- New research reveals high rates of hepatitis C infection among intravenous drug users and baby boomers seen in urban emergency departments. And three-quarters of those who tested positive for the potentially deadly virus did.....


News Quicklinks